For patients with moderate-to-severe ischemia but without obstructive coronary disease, the so-called INOCA patient, there is no correlation between the severity of ischemia on stress echocardiography ...

Older patients enrolled in the ISCHEMIA trial saw their angina symptoms improve with an invasive strategy as compared with more-conservative management, but unlike younger patients in the trial, they ...

Please provide your email address to receive an email when new articles are posted on . Despite having less ischemia and less extensive CAD compared with men, women had more frequent angina, according ...

Percutaneous coronary intervention successfully alleviated chest pain symptoms in select patients with chronic total occlusion and reduced the frequency of anginal events, a speaker ...

Importance Women with angina due to suspected ischaemia referred for coronary angiography often have no obstructive coronary ...

PHILADELPHIA -- It's COURAGE all over again: the landmark ISCHEMIA trial failed to show an outcome benefit from adding early stenting or bypass surgery to optimal medication in patients with stable, ...

Myocardial ischemia at stress testing may be just as severe without as with obstructive coronary artery disease (CAD) at angiography. But patients with ischemia and no obstructive CAD (INOCA) may have ...

Sir, you are no longer a maverick. We should have listened to you. It took over 40 years, but today, at the American Heart Association (AHA) Scientific Sessions 2019, we learned that you were right to ...

PARIS -- Whether a person had chest pains resolved by angioplasty hinged on the nature, not the severity, of their presenting symptoms, an ORBITA-2 analysis showed. Investigators found two groups more ...

Medically reviewed by Christopher Lee, MD Key Takeaways Ischemia is when there is a blockage of blood flow to a part of the ...

Calgary, Alberta--(Newsfile Corp. - September 16, 2025) - Hemostemix Inc. (HEM:CA) (OTCQB: HMTXF) (FSE: 2VF0), the leading autologous (patient's own) stem cell therapy company offering VesCell™ ...

SUNNYVALE, Calif., Sept. 18, 2025 (GLOBE NEWSWIRE) -- BioCardia, Inc. (NASDAQ: BCDA), a developer of cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, ...